Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
$12.50−0.24 (-1.88%)
Close on Nov 17, 2026Market cap $136.07MP/E –Yield –
Earnings
Burning Rock Biotech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q4 FY2025
CN¥126.30M
+0.2% on a year earlier
EPS, Q4 FY2025
-0.15 CNY
-0.79 CNY a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Burning Rock Biotech's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2025ended Dec 31, 2025 | Mar 13, 2026after the close | CN¥126.30M | +0.2% | -0.15 CNY | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 25, 2025before the open | CN¥126.00M | +4.0% | -0.79 CNY | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024during market hours | CN¥121.10M | – | -1.58 CNY | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 28, 2023before the open | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 31, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 22, 2022before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Burning Rock Biotech has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Burning Rock Biotech puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Burning Rock Biotech filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?